FDA Drug Topics: The Bad Ad Program - September 24, 2024
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present our FDA Drug Topic series of educational webinars targeting the needs of all health care professionals, including physicians, physician assistants, nurse practitioners, nurses, pharmacists, pharmacy technicians, and certified public health professionals. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, September 24, CDER's Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: The Bad Ad Program. There are several innovative opportunities to collaborate with the FDA. This webinar will focus in on the FDA's Bad Ad Program. It will provide an overview of prescription drug promotion and its regulation along with information on how healthcare professionals can report potentially false or misleading prescription drug promotion to the FDA.
View Presentation: FDA Drug Topics: The Bad Ad Program
Download Presentation Slides: The Bad Ad Program (PDF - 1.62MB)
Activity Outline and Continuing Education Information: U.S. Food & Drug Administration (fda.gov)